Patients who experience a nonaneurysmal subarachnoid hemorrhage differ from patients who suffer an aneurysmal subarachnoid hemorrhage in initial presentation (including neurological examination ...

Hyponatremia is a serum sodium concentration level of less than 135 mEq/L (< 135 mmole/L, SI) for at least 1 day (Kurokawa et al., 1996). A value of less than 120 mEq/L is considered a critical ...

Considering taking a vitamin or supplement to treat Subarachnoid+Hemorrhage? Below is a list of common natural remedies used to treat or reduce the symptoms of Subarachnoid+Hemorrhage. Follow the ...

Considering taking supplements to treat subarachnoid hemorrhage? Below is a list of common natural remedies used to treat or reduce the symptoms of subarachnoid hemorrhage. Follow the links to ...

Subarachnoid hemorrhage (SAH) is often followed by fever. The rise in brain temperature can lead to ischemic brain injury, hyperemia, exacerbation of cerebral edema, and increased intracranial ...

A quarter of people with subarachnoid hemorrhage die within 24 hours, and half die within the first six months. A rebleed has a mortality rate of 51-80%. Death is 62% more common in women than men ...

1. Kundra S, Mahendru V, Gupta V, Choudhary AK: Principles of neuroanesthesia in aneurysmal subarachnoid hemorrhage. J Anaesthesiol Clin Pharmacol 2014; 30: 328–37 CrossRef MEDLINE PubMed Central 2.

Strokes are the second leading cause of death and the third leading cause of disability in the world, according to the World ...

PIVLAZ™ is the first drug approved in South Korea for the prevention of Cerebral Vasospasm in patients with Aneurysmal ...

John McLaughlan, 53, has been given a minimum of 17 years in prison for the murder of his partner, Stacey Warnock, in Airdrie ...

Nxera Pharma Korea has entered into a partnership with Handok for marketing PIVLAZ 150mg in the South Korean market.

PIVLAZ is the first drug approved in South Korea for the prevention of Cerebral Vasospasm in patients with Aneurysmal Subarachnoid Hemorrhage. PIVLAZ will become commercially available in South Korea ...